594
A. Vinothkanna and S. Sekar
Table 24.3 Patents on the diagnosis of human cancers applying PBPs as fluorescent probes
Disease/diagnostic parameters
Patents-source/country and number
(A) Cancers in general
Tumor/cancer/multiple tumor markers
US 8071293, US 8354222, US 8361706, US
8535639, US 8940493, US 10018633, JP
2010-193876, JP 2016-029048, KR
1020047013664, KR 1020047020362,
CN101526535 (E), TW200501989 (E),
CN101144815 (E), IN 20167027880, IN
201727001584, IN 201817042344, IN
201838002349, IN 1019/CHENP/2014, IN
150/MUMNP/2014, IN 1966/DELNP/2010, IN
4262/DELNP/2005, IN 4566/KOLNP/2007, IN
6320/CHENP/2011, IN 6597/DELNP/2015, IN
9120/DELNP/2008, IN 928/CHENP/2006
Tumor-specific fusion proteins
US 7993850
Genomic abnormalities leading to pathology
and cancer
IN 4049/DELNP/2010
Pro-vasopressin expressing cancers
US 7790162, US 10155810
(B) Organ-specific cancers
Pancreatic cancer
US 7052859, US 7282567, US 8795662, US
8974784, US 9238084, US 9599619, IN
4773/CHENP/2012
Pancreatic adenocarcinoma
US 9238081, IN 4612/DELNP/2012
Hepatocellular carcinoma
US 9506925, CN109085362 (E),
CN 107271661
Colorectal cancer
US 8563682, CN100342034 (E), CN 1766615
Oral and nasopharyngeal cancer
IN 1921/DELNP/2011
Lung cancer
CN103383395 (E), CN103439511 (E),
CN103389375 (E), CN103305602 (E)
Mesothelioma
(Asbestos-related lung cancer)
IN 635/KOLNP/2013
Cancer bone metastasis
CN101571545 (E)
Breast carcinoma
US 8329875, CN 1012013570, IN
201641017874, IN 201717038976
Ovarian cancer
US 7462458, US 8252904, IN
4156/CHENP/2008, IN 450/KOLNP/2007
Ovarian and breast cancer
IN 48/MUMNP/2010
Cervical cancer
US 7067268, US 7901883, US 8017757, US
8389217, IN 2414/CHENP/2007, IN
3382/DELNP/2015, IN 4185/KOLNP/2007, IN
554/CHENP/2005
Prostate carcinoma
US 8691183, US 9891224, CN 101942523
(C) Blood-related cancers
(continued)